AMN · Amn Healthcare Services Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.38B | - | $634.50M | $658.17M | $689.53M | - | $687.51M | $740.68M | $820.88M | - |
| Cost of Revenue | $1.01B | - | $450.08M | $461.78M | $491.41M | - | $474.45M | $510.86M | $563.37M | - |
| Gross Profit | $368.84M | - | $184.41M | $196.40M | $198.12M | - | $213.06M | $229.83M | $257.51M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $218.43M | - | $138.59M | $154.58M | $147.73M | - | $149.68M | $149.04M | $174.84M | - |
| Total Operating Expenses | $251.66M | - | $136.79M | $320.11M | $185.61M | - | $190.80M | $192.15M | $217.56M | - |
| D&A | $35.66M | - | $37.38M | $37.75M | $39.86M | - | $41.12M | $43.10M | $44.52M | - |
| Operating Income | $117.17M | - | $47.62M | ($123.72M) | $12.51M | - | $22.25M | $37.68M | $39.95M | - |
| Interest Expense | $6.71M | - | $9.63M | $11.36M | $16.63M | - | $11.54M | $15.71M | $16.63M | - |
| Income Tax | $48.29M | - | $8.70M | ($18.87M) | $1.27M | - | $819.0K | $5.73M | $5.99M | - |
| Net Income | $62.17M | - | $29.29M | ($116.20M) | ($1.09M) | - | $6.99M | $16.24M | $17.33M | - |
| EPS - Basic | $1.60 | - | $0.76 | ($3.02) | ($0.03) | - | $0.18 | $0.43 | $0.45 | - |
| EPS - Diluted | $1.59 | - | $0.76 | ($3.02) | ($0.03) | - | $0.18 | $0.42 | $0.45 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $560.74M | $33.97M | $52.64M | $41.50M | $55.78M | $10.65M | $30.55M | $48.04M | $50.56M | $32.94M |
| Accounts Receivable | $394.67M | $382.56M | $391.10M | $387.77M | $421.87M | $437.82M | $451.06M | $508.91M | $578.65M | $623.49M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $197.38M | $161.97M | $171.13M | $175.62M | $195.97M | $184.31M | $213.21M | $283.18M | $316.02M | $343.85M |
| Current Assets | $1.14B | $545.38M | $570.32M | $571.35M | $627.36M | $594.91M | $612.27M | $704.76M | $790.75M | $841.68M |
| Total Assets | $2.60B | $2.09B | $2.14B | $2.21B | $2.40B | $2.42B | $2.67B | $2.77B | $2.87B | $2.92B |
| Current Liabilities | $1.04B | $577.61M | $542.16M | $573.64M | $582.25M | $545.78M | $518.55M | $573.89M | $623.90M | $656.12M |
| Long-term Debt | - | $767.05M | - | - | - | $1.06B | - | - | - | $1.30B |
| Total Liabilities | $1.89B | $1.45B | $1.49B | $1.60B | $1.68B | $1.71B | $1.78B | $1.89B | $2.02B | $2.09B |
| Stockholders' Equity | $712.81M | $642.11M | $644.41M | $607.60M | $715.05M | $706.62M | $890.66M | $876.86M | $854.19M | $831.26M |
| Retained Earnings | $1.27B | $1.21B | $1.22B | $1.19B | $1.30B | $1.30B | $1.49B | $1.49B | $1.47B | $1.45B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $562.45M | - | - | - | $92.67M | - | - | - | $81.39M | - |
| Investing Cash Flow | ($7.50M) | - | - | - | ($26.05M) | - | - | - | ($21.40M) | - |
| Financing Cash Flow | ($27.14M) | - | - | - | ($61.21M) | - | - | - | ($38.97M) | - |
| CapEx | $7.25M | - | - | - | $9.97M | - | - | - | $18.14M | - |
| Free Cash Flow | $555.21M | - | - | - | $82.70M | - | - | - | $63.24M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 26.8% | - | 29.1% | 29.8% | 28.7% | - | 31.0% | 31.0% | 31.4% | - |
| Operating margin | 8.5% | - | 7.5% | -18.8% | 1.8% | - | 3.2% | 5.1% | 4.9% | - |
| EBITDA margin | 11.1% | - | 13.4% | -13.1% | 7.6% | - | 9.2% | 10.9% | 10.3% | - |
| Net margin | 4.5% | - | 4.6% | -17.7% | -0.2% | - | 1.0% | 2.2% | 2.1% | - |
| Free cash flow margin | 40.3% | - | - | - | 12.0% | - | - | - | 7.7% | - |
| FCF / Net income | 8.93 | - | - | - | -75.73 | - | - | - | 3.65 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 15.8% | - | 21.8% | 23.5% | 21.4% | - | 21.8% | 20.1% | 21.3% | - |
| Effective tax rate | 43.7% | - | 22.9% | - | 696.7% | - | 10.5% | 26.1% | 25.7% | - |
| Return on assets | 2.4% | - | 1.4% | -5.3% | -0.0% | - | 0.3% | 0.6% | 0.6% | - |
| Return on equity | 8.7% | - | 4.5% | -19.1% | -0.2% | - | 0.8% | 1.9% | 2.0% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.09 | 0.94 | 1.05 | 1.00 | 1.08 | 1.09 | 1.18 | 1.23 | 1.27 | 1.28 |
| Quick ratio | 1.09 | 0.94 | 1.05 | 1.00 | 1.08 | 1.09 | 1.18 | 1.23 | 1.27 | 1.28 |
| Cash ratio | 0.54 | 0.06 | 0.10 | 0.07 | 0.10 | 0.02 | 0.06 | 0.08 | 0.08 | 0.05 |
| Leverage | ||||||||||
| Debt / Equity | - | 1.19 | - | - | - | 1.49 | - | - | - | 1.57 |
| Debt / Assets | - | 0.37 | - | - | - | 0.44 | - | - | - | 0.45 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 17.5x | - | 4.9x | -10.9x | 0.8x | - | 1.9x | 2.4x | 2.4x | - |
| Equity multiplier | 3.65 | 3.26 | 3.32 | 3.64 | 3.35 | 3.42 | 3.00 | 3.16 | 3.36 | 3.52 |
| Liabilities / Assets | 0.73 | 0.69 | 0.70 | 0.73 | 0.70 | 0.71 | 0.67 | 0.68 | 0.70 | 0.72 |
| Efficiency | ||||||||||
| Asset turnover | 0.53 | - | 0.30 | 0.30 | 0.29 | - | 0.26 | 0.27 | 0.29 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 105d | - | 225d | 215d | 223d | - | 239d | 251d | 257d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | 71d | - | 139d | 139d | 146d | - | 164d | 202d | 205d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 11.5x | - | 25.5x | - | - | - | 235.5x | 122.0x | 138.9x | - |
| P / B | 1.0x | - | 1.2x | 1.3x | 1.3x | - | 1.8x | 2.2x | 2.8x | - |
| P / S | 0.5x | - | 1.2x | 1.2x | 1.4x | - | 2.4x | 2.6x | 2.9x | - |
| EV / EBITDA | 1.0x | - | 8.2x | - | 16.8x | - | 25.1x | 23.7x | 27.7x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 99.9% | - | -7.7% | -11.1% | -16.0% | - | -19.4% | -25.3% | -27.1% | - |
| Revenue CAGR (3y) | 7.0% | - | -17.7% | -22.7% | -23.7% | - | -7.8% | -4.8% | -2.5% | - |
| Revenue CAGR (5y) | 9.2% | - | 2.8% | 1.6% | 2.7% | - | 3.9% | 6.7% | 9.0% | - |
| Gross profit growth (YoY) | 86.2% | - | -13.4% | -14.5% | -23.1% | - | -26.4% | -30.4% | -30.2% | - |
| Operating income growth (YoY) | 836.8% | - | 114.0% | - | -68.7% | - | -74.4% | -58.9% | -68.2% | - |
| Net income growth (YoY) | - | - | 319.1% | - | - | - | -86.9% | -73.3% | -79.4% | - |
| EPS growth (YoY) | - | - | 322.2% | - | - | - | -87.1% | -72.9% | -77.7% | - |
| EPS CAGR (3y) | -7.7% | - | -28.7% | - | - | - | -51.1% | -32.9% | -32.6% | - |
| EPS CAGR (5y) | 1.6% | - | 6.7% | - | - | - | -18.2% | -7.2% | -8.7% | - |
| FCF growth (YoY) | 571.4% | - | - | - | 30.8% | - | - | - | 143.7% | - |
| FCF CAGR (5y) | 82.4% | - | - | - | 17.0% | - | - | - | 17.0% | - |
| Book value growth (YoY) | -0.3% | -9.1% | -27.6% | -30.7% | -16.3% | -15.0% | 9.0% | 14.4% | -10.6% | -20.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$2.73B totalNurse And Allied Healthcare Staffing$1.65B · 60.3%
Physician And Leadership Solutions$696.36M · 25.5%
Technology And Workforce Solutions$386.75M · 14.2%
Product / service
$4.97B totalTemporary Staffing$1.64B · 33.0%
Travel Nurse Staffing$827.68M · 16.7%
Allied Staffing$582.32M · 11.7%
Locum Tenens Staffing$565.17M · 11.4%
Technology Enabled Services$375.86M · 7.6%
Language Services$295.51M · 6.0%
Labor Disruption Services$191.19M · 3.9%
International Nurse$129.09M · 2.6%
International Nurse Staffing$119.77M · 2.4%
Interim Leadership Staffing$93.92M · 1.9%
Vendor Management Systems$71.67M · 1.4%
Local Staffing$36.81M · 0.7%
Talent Planning And Acquisition$10.88M · 0.2%
International Nurse Permanent Placement$9.32M · 0.2%
Permanent Placement$9.32M · 0.2%
Other Technologies$8.68M · 0.2%
Peer comparison
Same SIC group: Services-Help Supply Services
Comparing AMN HEALTHCARE SERVICES INC against the 5 most active filers in the same SIC group.